SYNERGISTIC ANTITUMOR EFFECT OF NAPROXEN AND SORAFENIB IN HEPATOCELLULAR CARCINOMA
E. Akar, S. Unsal Beyge, D. C. Kahraman
This study investigates the synergistic antitumor effect of naproxen and sorafenib in hepatocellular carcinoma, showing enhanced apoptosis through PI3K/AKT pathway inhibition and CAPN2 downregulation.
bioRxiv · Feb 1, 2024 · PreprintCancer Biology